U.S. Senate · 118th Congress · S. 5459
Biosimilars Access and Affordability Act
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Marsha BlackburnR-TN
- Introduced
- December 9, 2024, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (0)
No member has cosponsored this bill.